Terazosin-hydrochloride-dihydrate-Standard-生命科學(xué)試劑-MCE

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemETerazosinhydrochloridedihydrate(Standard)Cat.No.:HY-B0371ARCASNo.:70024-40-7分?式:C??H??ClN?O?分?量:459.92作?靶點(diǎn):AdrenergicReceptor作?通路:GPCR/GProtein;NeuronalSignaling儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性Terazosin(hydrochloridedihydrate)(Standard)Terazosin(hydrochloridedihydrate)的分析標(biāo)準(zhǔn)品。本產(chǎn)品?于研究及分析應(yīng)?。Terazosinhydrochloridedihydrate?種喹唑啉衍?物，也?種競(jìng)爭(zhēng)性和?服活性的α1-腎上腺素受體(α1-adrenoceptor)拮抗劑。Terazosinhydrochloridedihydrate通過(guò)舒張?管和打開(kāi)膀胱來(lái)起作?。Terazosinhydrochloridedihydrate可?于良性前列腺增?(BPH)和??壓的研究。IC50&Targetα1-adrenoceptor[1]REFERENCES[1].MichelMC,etal.Drugsfortreatmentofbenignprostatichyperplasia:affinitycomparisonatclonedalpha1-adrenoceptorsubtypesandinhumanprostate.JAutonPharmacol.1996Feb;16(1):21-8.[2].VincentJ,etal.Pharmacologicaltolerancetoalpha1-adrenergicreceptorantagonismmediatedbyterazosininhumans.JClinInvest.1992Nov;90(5):1763-8.[3].JuM,etal.Efficacyofcombinationterazosinandnifedipinetherapyinpostoperativetreatmentofdistalureteralstonesaftertransurethralureteroscopiclithotripsy.JIntMedRes.2020Apr;48(4):300060520904851.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplications.Forresearchuseonly.Tel:400-820-3792ax:021-